Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
106,3 USD | +2,71% | +4,58% | +6,62% |
31/05 | ICU Medical Insider verkocht aandelen ter waarde van $1.303.485, volgens een recent SEC-document | MT |
08/05 | Aangepaste winst ICU Medical's Q1, omzet daalt | MT |
Omzet 2024 * | 2,28 mld. 2,1 mld. | Omzet 2025 * | 2,36 mld. 2,18 mld. | Marktkapitalisatie | 2,59 mld. 2,39 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -70 mln. -64,55 mln. | Nettowinst (verlies) 2025 * | 41 mln. 37,81 mln. | EV/omzet 2024 * | 1,75 x |
Nettoschuld 2024 * | 1,38 mld. 1,28 mld. | Nettoschuld 2025 * | 1,23 mld. 1,14 mld. | EV/omzet 2025 * | 1,62 x |
K/w-verhouding 2024 * |
-33,9
x | K/w-verhouding 2025 * |
164
x | Werknemers | 14.000 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 86,96% |
Recentste transcriptie over ICU Medical, Inc.
1 dag | +2,71% | ||
1 week | +4,58% | ||
1 maand | +8,19% | ||
3 maanden | +0,90% | ||
6 maanden | +16,42% | ||
Lopend jaar | +6,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vivek Jain
CEO | Chief Executive Officer | 52 | 13-02-14 |
Brian Bonnell
DFI | Director of Finance/CFO | 50 | 01-05-18 |
Chief Tech/Sci/R&D Officer | - | 01-03-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 69 | 05-01-18 | |
Kolleen Kennedy
BRD | Director/Board Member | 63 | 31-12-21 |
Vivek Jain
CEO | Chief Executive Officer | 52 | 13-02-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.15% | 14 M€ | -5,07% | ||
0.65% | 2 M€ | -.--% | ||
0.38% | 8 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 106,3 | +2,71% | 366 861 |
30-05-24 | 103,5 | +2,36% | 161 782 |
29-05-24 | 101,1 | -3,58% | 133 853 |
28-05-24 | 104,9 | +3,17% | 245 624 |
24-05-24 | 101,7 | -2,50% | 218 119 |
uitgestelde koers Nasdaq, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,62% | 2,59 mld. | |
-7,16% | 178 mld. | |
-1,23% | 107 mld. | |
-4,86% | 67,04 mld. | |
-4,28% | 47,23 mld. | |
+10,32% | 44,62 mld. | |
+8,14% | 42,5 mld. | |
+15,76% | 29,99 mld. | |
+15,53% | 25,22 mld. | |
-5,88% | 24,14 mld. |